Befejeződött1. fázis
An open-label, phase I multicenter, clinical trial of NECVAX-NEO1 in addition to anti-PD-1 or anti-PD-L1 monoclonal antibody checkpoint inhibitor monotherapy in patients with solid tumors
Key facts
- Where
- Kaunas és Vilnius, LitvániaSee the 2 sites
- Phase
- 1. fázis
Where in Litvánia
- Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikosKaunas, LitvániaNo longer taking part
- Nacionalinis Vezio InstitutasVilnius, LitvániaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Nec Oncoimmunity AS
- Trial code
- EU 2024-513716-95-00
- Record updated
- 2025. július 23.